Research & Literature

Mouse models of autoimmune uveitis.

Klaska IP, Forrester JV

Current pharmaceutical design 2015; (21(18)):2453-67 doi:10.2174/1381612821666150316122928.

Benefits of Systemic Anti-inflammatory Therapy versus Fluocinolone Acetonide Intraocular Implant for Intermediate Uveitis, Posterior Uveitis, and Panuveitis: Fifty-four-Month Results of the Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study.

, Kempen JH, Altaweel MM, et al.

Ophthalmology 2015; (122(10)):1967-75.

Results of intravitreal dexamethasone implant 0.7 mg (Ozurdex®) in non-infectious posterior uveitis.

Yap YC, Papathomas T, Kamal A

International journal of ophthalmology 2015; (8(4)):835-8 doi:10.3980/j.issn.2222-3959.2015.04.34.

Posterior Uveitis.

Uy HS, Yu-Keh E, Chan PS

Developments in ophthalmology 2016; (55()):163-6 doi:10.1159/000438968.

DADS neuropathy associated with anti-TNF-α therapy.

McGinty RN, McNamara B, Moore H

BMJ case reports 2015; (2015()).

Role of Ultra-Wide Field Imaging in the Management of Tubercular Posterior Uveitis.

Aggarwal K, Mulkutkar S, Mahajan S, et al.

Ocular immunology and inflammation 2016; (24(6)):631-636 doi:10.3109/09273948.2015.1099681.

Primary vitreoretinal lymphoma: an update on pathogenesis, diagnosis and treatment.

Reichstein D

Current opinion in ophthalmology 2016; (27(3)):177-84 doi:10.1097/ICU.0000000000000255.

Treatment of Non-infectious Uveitic Macular Edema with the Intravitreal Dexamethasone Implant.

Nobre-Cardoso J, Champion E, Darugar A, et al.

Ocular immunology and inflammation 2017; (25(4)):447-454 doi:10.3109/09273948.2015.1132738.

Clinical Features of Ocular Sarcoidosis in Patients with Biopsy-proven Pulmonary Sarcoidosis in Serbia.

Radosavljević A, Jakšić V, Pezo L, et al.

Ocular immunology and inflammation 2017; (25(6)):785-789 doi:10.3109/09273948.2016.1167224.

Uveitic macular edema.

Fardeau C, Champion E, Massamba N, LeHoang P

Eye (London, England) 2016; (30(10)):1277-1292 doi:10.1038/eye.2016.115.

Spectral-domain optical coherence tomography findings of the macula in 500 consecutive patients with uveitis.

Grajewski RS, Boelke AC, Adler W, et al.

Eye (London, England) 2016; (30(11)):1415-1423 doi:10.1038/eye.2016.133.

Diagnostic Value of the Serum Anti-Toxocara IgG Titer for Ocular Toxocariasis in Patients with Uveitis at a Tertiary Hospital in Korea.

Bae KW, Ahn SJ, Park KH, Woo SJ

Korean journal of ophthalmology : KJO 2016; (30(4)):258-64 doi:10.3341/kjo.2016.30.4.258.

Multimodal Imaging of the White Dot Syndromes and Related Diseases.

Knickelbein JE, Sen HN

Journal of clinical & experimental ophthalmology 2016; (7(3)).

Adalimumab in Patients with Active Noninfectious Uveitis.

Jaffe GJ, Dick AD, Brézin AP, et al.

The New England journal of medicine 2016; (375(10)):932-43 doi:10.1056/NEJMoa1509852.

Management of noninfectious posterior uveitis with intravitreal drug therapy.

Tan HY, Agarwal A, Lee CS, et al.

Clinical ophthalmology (Auckland, N.Z.) 2016; (10()):1983-2020 doi:10.2147/OPTH.S89341.

Aqueous humor polymerase chain reaction in uveitis - utility and safety.

Chronopoulos A, Roquelaure D, Souteyrand G, et al.

BMC ophthalmology 2016; (16(1)):189 doi:10.1186/s12886-016-0369-z.

Viral posterior uveitis.

Lee JH, Agarwal A, Mahendradas P, et al.

Survey of ophthalmology 2017; (62(4)):404-445 doi:10.1016/j.survophthal.2016.12.008.

Diagnosis and Treatment of Acute Retinal Necrosis: A Report by the American Academy of Ophthalmology.

Schoenberger SD, Kim SJ, Thorne JE, et al.

Ophthalmology 2017; (124(3)):382-392 doi:10.1016/j.ophtha.2016.11.007.

LONG-TERM OUTCOMES OF RITUXIMAB THERAPY IN PATIENTS WITH NONINFECTIOUS POSTERIOR UVEITIS REFRACTORY TO CONVENTIONAL IMMUNOSUPPRESSIVE THERAPY.

Lasave AF, You C, Ma L, et al.

Retina (Philadelphia, Pa.) 2018; (38(2)):395-402 doi:10.1097/IAE.0000000000001563.

Contribution of dual fluorescein and indocyanine green angiography to the appraisal of posterior involvement in birdshot retinochoroiditis and Vogt-Koyanagi-Harada disease.

Balci O, Jeannin B, Herbort CP

International ophthalmology 2018; (38(2)):527-539 doi:10.1007/s10792-017-0487-5.

CNS Demyelination with TNF-α Blockers.

Kemanetzoglou E, Andreadou E

Current neurology and neuroscience reports 2017; (17(4)):36 doi:10.1007/s11910-017-0742-1.

Bacterial and Fungal Endophthalmitis.

Durand ML

Clinical microbiology reviews 2017; (30(3)):597-613 doi:10.1128/CMR.00113-16.

[Prognostic factors in uveitis].

Albaroudi N, Tijani M, Boutimzine N, et al.

Journal francais d'ophtalmologie 2017; (40(9)):751-757 doi:10.1016/j.jfo.2017.04.005.

Uveitis: Diagnostic work-up. A literature review and recommendations from an expert committee.

Sève P, Cacoub P, Bodaghi B, et al.

Autoimmunity reviews 2017; (16(12)):1254-1264 doi:10.1016/j.autrev.2017.10.010.

Characteristic optical coherence tomography findings in patients with primary vitreoretinal lymphoma: a novel aid to early diagnosis.

Barry RJ, Tasiopoulou A, Murray PI, et al.

The British journal of ophthalmology 2018; (102(10)):1362-1366 doi:10.1136/bjophthalmol-2017-311612.

Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 1: risk assessment.

Park DI, Hisamatsu T, Chen M, et al.

Intestinal research 2018; (16(1)):4-16 doi:10.5217/ir.2018.16.1.4.

DIFFERENTIAL DIAGNOSIS FOR VITREORETINAL LYMPHOMA WITH VITREORETINAL FINDINGS, IMMUNOGLOBULIN CLONALITY TESTS, AND INTERLEUKIN LEVELS.

Lee J, Kim SW, Kim H, et al.

Retina (Philadelphia, Pa.) 2019; (39(6)):1165-1176 doi:10.1097/IAE.0000000000002127.

Assessment of diagnostic and therapeutic vitrectomy for vitreous opacity associated with uveitis with various etiologies.

Sato T, Kinoshita R, Taguchi M, et al.

Medicine 2018; (97(2)):e9491 doi:10.1097/MD.0000000000009491.

Autoimmunity, Autoinflammation, and Infection in Uveitis.

Forrester JV, Kuffova L, Dick AD

American journal of ophthalmology 2018; (189()):77-85 doi:10.1016/j.ajo.2018.02.019.

Non-syndromic retinitis pigmentosa.

Verbakel SK, van Huet RAC, Boon CJF, et al.

Progress in retinal and eye research 2018; (66()):157-186 doi:10.1016/j.preteyeres.2018.03.005.

Need for Quantitative Measurement Methods for Posterior Uveitis: Comparison of Dual FA/ICGA Angiography, EDI-OCT Choroidal Thickness and SUN Vitreous Haze Evaluation in Stromal Choroiditis.

Fabro F, Herbort CP

Klinische Monatsblatter fur Augenheilkunde 2018; (235(4)):424-435 doi:10.1055/s-0043-124966.

[Endophthalmitis].

Neß T

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 2018; (115(8)):697-706 doi:10.1007/s00347-018-0729-6.

Primary Vitreoretinal Lymphoma Presenting as a Posterior Capsule Plaque.

Hussain RM, Garoon RB, Duker JS, et al.

Ophthalmic surgery, lasers & imaging retina 2018; (49(9)):732-734 doi:10.3928/23258160-20180831-15.

An unusual case report of primary vitreoretinal lymphoma.

Tan SZ, Steeples LR, Chhabra R, Jones NP

BMC ophthalmology 2018; (18(Suppl 1)):223 doi:10.1186/s12886-018-0860-9.

Disease of the Year: Differential Diagnosis of Uveitic Macular Edema.

Agarwal A, Pichi F, Invernizzi A, Gupta V

Ocular immunology and inflammation 2019; (27(1)):72-88 doi:10.1080/09273948.2018.1523437.

COMBINED VITRECTOMY WITH INTRAVITREAL DEXAMETHASONE IMPLANT FOR REFRACTORY MACULAR EDEMA SECONDARY TO DIABETIC RETINOPATHY, RETINAL VEIN OCCLUSION, AND NONINFECTIOUS POSTERIOR UVEITIS.

Pang JP, Son G, Yoon YH, et al.

Retina (Philadelphia, Pa.) 2020; (40(1)):56-65 doi:10.1097/IAE.0000000000002358.

Effect of an Injectable Fluocinolone Acetonide Insert on Recurrence Rates in Chronic Noninfectious Uveitis Affecting the Posterior Segment: Twelve-Month Results.

Jaffe GJ, Foster CS, Pavesio CE, et al.

Ophthalmology 2019; (126(4)):601-610 doi:10.1016/j.ophtha.2018.10.033.

Vertical Hyperreflective Lesions on Optical Coherence Tomography in Vitreoretinal Lymphoma.

Deák GG, Goldstein DA, Zhou M, et al.

JAMA ophthalmology 2019; (137(2)):194-198 doi:10.1001/jamaophthalmol.2018.5835.

RETINAL FINDINGS IN PRESUMED INFECTIOUS POSTERIOR UVEITIS AND CORRELATION WITH POLYMERASE CHAIN REACTION RESULTS.

Elyashiv SM, Samson CM, Jabs DA

Retina (Philadelphia, Pa.) 2020; (40(3)):567-571 doi:10.1097/IAE.0000000000002423.

The ghost of the great imitator: prognostic factors for poor outcome in syphilitic uveitis.

Queiroz RP, Inês DV, Diligenti FT, et al.

Journal of ophthalmic inflammation and infection 2019; (9(1)):2 doi:10.1186/s12348-019-0169-8.

Effect of Corticosteroid-Sparing Treatment With Mycophenolate Mofetil vs Methotrexate on Inflammation in Patients With Uveitis: A Randomized Clinical Trial.

Rathinam SR, Gonzales JA, Thundikandy R, et al.

JAMA 2019; (322(10)):936-945 doi:10.1001/jama.2019.12618.

Long-Term Outcomes of Treatment with Biological Agents in Eyes with Refractory, Active, Noninfectious Intermediate Uveitis, Posterior Uveitis, or Panuveitis.

Al-Janabi A, El Nokrashy A, Sharief L, et al.

Ophthalmology 2020; (127(3)):410-416 doi:10.1016/j.ophtha.2019.08.031.

Intravitreal Dexamethasone Implant in the Treatment of Non-infectious Uveitis

Hasanreisoğlu M, Özdemir HB, Özkan K, et al.

Turkish journal of ophthalmology 2019; (49(5)):250-257 doi:10.4274/tjo.galenos.2019.81594.

The Detection of Occult Retinal Vasculitis on Fluorescein Angiography in Pediatric Uveitis.

Abraham A, Saboo US, Ducca BL, et al.

Ophthalmology. Retina 2020; (4(2)):198-203 doi:10.1016/j.oret.2019.09.007.

Visual Acuity Outcome over Time in Non-Infectious Uveitis.

Pistilli M, Joffe MM, Gangaputra SS, et al.

Ocular immunology and inflammation 2021; (29(6)):1064-1071 doi:10.1080/09273948.2019.1687733.

Ozurdex (dexamethasone intravitreal implant) for the treatment of intermediate, posterior, and panuveitis: a systematic review of the current evidence.

Saincher SS, Gottlieb C

Journal of ophthalmic inflammation and infection 2020; (10(1)):1 doi:10.1186/s12348-019-0189-4.

[Congenital Retinal Dystrophies: Combining Ophthalmological Techniques to Improve the Read-out].

Kellner U, Kellner S, Saleh M, et al.

Klinische Monatsblatter fur Augenheilkunde 2020; (237(3)):275-287 doi:10.1055/a-1118-3705.

Outcomes in patients with chronic uveitis: which factors matter to patients? A qualitative study.

Stolk-Vos AC, Kasigar H, Nijmeijer KJ, et al.

BMC ophthalmology 2020; (20(1)):125 doi:10.1186/s12886-020-01388-y.

Clinical utility of aqueous humor polymerase chain reaction and serologic testing for suspected infectious uveitis: a single-center retrospective study in South Korea.

Choi W, Kang HG, Choi EY, et al.

BMC ophthalmology 2020; (20(1)):242 doi:10.1186/s12886-020-01513-x.

Seronegative ocular toxoplasma panuveitis in an immunocompetent patient.

Sigle M, El Atrouni W, Ajlan RS

American journal of ophthalmology case reports 2020; (19()):100745 doi:10.1016/j.ajoc.2020.100745.

Effect of a Fluocinolone Acetonide Insert on Recurrence Rates in Noninfectious Intermediate, Posterior, or Panuveitis: Three-Year Results.

Jaffe GJ, Pavesio CE,

Ophthalmology 2020; (127(10)):1395-1404 doi:10.1016/j.ophtha.2020.04.001.

Multimodality Approach to the Diagnosis and Assessment of Uveitic Macular Edema.

Khochtali S, Tugal-Tutkun I, Fardeau C, et al.

Ocular immunology and inflammation 2020; (28(8)):1212-1222 doi:10.1080/09273948.2020.1797112.

Vascular abnormalities in uveitis.

Ebrahimiadib N, Maleki A, Fadakar K, et al.

Survey of ophthalmology 2021; (66(4)):653-667 doi:10.1016/j.survophthal.2020.12.006.

Diagnosis of Inherited Retinal Diseases.

Birtel J, Yusuf IH, Priglinger C, et al.

Klinische Monatsblatter fur Augenheilkunde 2021; (238(3)):249-259 doi:10.1055/a-1388-7236.

Relevance of Brain MRI in Patients with Uveitis: Retrospective Cohort on 402 Patients.

Chirpaz NM, Kerever SMP, Gavoille AM, et al.

Ocular immunology and inflammation 2022; (30(5)):1109-1115 doi:10.1080/09273948.2020.1870145.

Ocular syphilis.

Tsan GL, Claiborne RT

Clinical & experimental optometry 2021; (104(7)):756-759 doi:10.1080/08164622.2021.1906848.

Structural Endpoints and Outcome Measures in Uveitis.

Wintergerst MWM, Liu X, Terheyden JH, et al.

Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde 2021; (244(5)):465-479 doi:10.1159/000517521.

IOP Elevation in Patients Treated With Fluocinolone Acetonide Insert for Chronic Noninfectious Uveitis Affecting the Posterior Segment.

Singer MA, Krambeer C, Paggiarino D

Ophthalmic surgery, lasers & imaging retina 2021; (52(7)):387-390 doi:10.3928/23258160-20210628-05.

[Development of classification criteria for uveitis by the standardization of uveitis nomenclature (SUN) working group].

Heiligenhaus A, Rothaus K, Pleyer U

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 2021; (118(9)):913-918 doi:10.1007/s00347-021-01486-2.

Methotrexate Effectively Controls Ocular Inflammation in Japanese Patients With Non-infectious Uveitis.

Harada Y, Hiyama T, Kiuchi Y

Frontiers in medicine 2021; (8()):732427 doi:10.3389/fmed.2021.732427.

The Use of Sustained Release Intravitreal Steroid Implants in Non-Infectious Uveitis Affecting the Posterior Segment of the Eye.

Abdulla D, Ali Y, Menezo V, Taylor SRJ

Ophthalmology and therapy 2022; (11(2)):479-487 doi:10.1007/s40123-022-00456-4.

Microvascular changes in the recurrent cystoid macular edema secondary to posterior noninfectious uveitis on optical coherence tomography angiography.

Albano V, Guerriero S, Furino C, et al.

International ophthalmology 2022; (42(11)):3285-3293 doi:10.1007/s10792-022-02327-0.

Single Institution Experience of Intravitreal 0.18-mg Fluocinolone Acetonide Implant for Noninfectious Uveitis.

Reddy AK, Pecen PE, Patnaik JL, Palestine AG

Ophthalmology. Retina 2023; (7(1)):67-71 doi:10.1016/j.oret.2022.07.002.

Steroid-induced delayed diagnosis of primary vitreoretinal lymphoma with ghost brain tumor: A case report.

Kau HC, Wang CJ, Tsai CC

Medicine 2022; (101(29)):e29637 doi:10.1097/MD.0000000000029637.

The standardisation of uveitis nomenclature (SUN) project.

Jabs DA, McCluskey P, Palestine AG, et al.

Clinical & experimental ophthalmology 2022; doi:10.1111/ceo.14175.

Evidence-based expert consensus on the management of primary central nervous system lymphoma in China.

Chen T, Liu Y, Wang Y, et al.

Journal of hematology & oncology 2022; (15(1)):136 doi:10.1186/s13045-022-01356-7.

Primary Vitreoretinal Lymphoma: Current Diagnostic Laboratory Tests and New Emerging Molecular Tools.

Melli B, Gentile P, Nicoli D, et al.

Current oncology (Toronto, Ont.) 2022; (29(10)):6908-6921 doi:10.3390/curroncol29100543.

Patient Clinical Outcomes in Standalone Versus a Combined Ophthalmology-rheumatology Uveitis Clinic.

Ross BX, Habhab S, Syeda S, et al.

Journal of ophthalmic inflammation and infection 2022; (12(1)):36 doi:10.1186/s12348-022-00314-1.

Diagnostic Accuracy of Vitreous Cytology in Patients with Vitreoretinal Lymphoma.

Lee D, Lee J, Nahm JH, Kim M

Journal of clinical medicine 2022; (11(21)) doi:10.3390/jcm11216450.

A review of patient-reported outcome measures used in uveitis.

Senthil MP, Simon S, Constable PA

Survey of ophthalmology 2023; (68(2)):225-240 doi:10.1016/j.survophthal.2022.11.004.

Interpreting posterior uveitis by integrating indocyanine green angiography, optical coherence tomography, and optical coherence tomography angiography data: A narrative review.

Chandrasekaran PR, Aljneibi S, Agarwal A, et al.

Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society 2022; (36(4)):344-355 doi:10.4103/sjopt.sjopt_69_22.

Optical Coherence Tomography Angiography Findings in Ocular Toxoplasmosis with Multiple Recurrences.

Sofia O, Wahyudi INSA, Fitri LE, et al.

International medical case reports journal 2023; (16()):35-43 doi:10.2147/IMCRJ.S395600.

Diagnostic and therapeutic results of aqueous real-time polymerase chain reaction in infectious uveitis.

Tombolini B, Menean M, Cicinelli MV, et al.

Canadian journal of ophthalmology. Journal canadien d'ophtalmologie 2024; (59(4)):e365-e370 doi:10.1016/j.jcjo.2023.05.011.

[Intermediate and Posterior Uveitis - Classification, diagnostics, complications, and therapeutic algorithms].

Heinz C, Baquet-Walscheid K

Klinische Monatsblatter fur Augenheilkunde 2023; (240(12)):1433-1447 doi:10.1055/a-2193-2509.

The 0.2-μg/day Fluocinolone Acetonide Intravitreal Implant in Chronic Noninfectious Posterior Uveitis: A 3-year Randomized Trial in India.

Biswas J, Tyagi M, Agarwal M,

Ophthalmology science 2024; (4(1)):100403 doi:10.1016/j.xops.2023.100403.

Multimodal Imaging of Vitreo-Retinal Lymphoma: A Comprehensive Review.

Rissotto F, Cicinelli MV, Servillo A, et al.

Ocular immunology and inflammation 2024; (32(9)):1983-1989 doi:10.1080/09273948.2024.2311754.

American Society of Retina Specialists Clinical Practice Guidelines on Multimodal Imaging for Retinal Disease.

Ramakrishnan MS, Kovach JL, Wykoff CC, et al.

Journal of vitreoretinal diseases 2024; (8(3)):234-246 doi:10.1177/24741264241237012.

Defining Retinal Vasculitis.

Davis JL

American journal of ophthalmology 2024; (267()):84-89 doi:10.1016/j.ajo.2024.05.030.

Ocular Syphilis in Patients With Nonreactive Rapid Plasma Reagin and Positive Treponemal Serologies: A Retrospective Observational Cohort Study.

Mohareb AM, Barshak MB, Papaliodis GN, et al.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2026; (81(6)):1194-1200 doi:10.1093/cid/ciae354.

Brief research report: ETS-1 blockade increases ICAM-1 expression in activated human retinal endothelial cells.

Tan ACR, Ma Y, Appukuttan B, et al.

Frontiers in ophthalmology 2024; (4()):1384428 doi:10.3389/fopht.2024.1384428.

Development of a Consensus Guideline for the Diagnosis and Management of Chronic Noninfectious Uveitis Affecting the Posterior Segment.

Singh RP, Albini TA, Baumal CR, et al.

Ophthalmic surgery, lasers & imaging retina 2024; (55(11)):652-658 doi:10.3928/23258160-20240625-01.

Prevalence and risk factors for complicated immuno-mediated uveitis: experience in a tertiary hospital.

Luque-Linero P, Espejo-González A, Navarrete-Navarrete N

Archivos de la Sociedad Espanola de Oftalmologia 2024; (99(12)):540-547 doi:10.1016/j.oftale.2024.06.013.

Self-Perceived Difficulty in Job Performance by Working Patients with Uveitis: Global Assessment and by Subscales of Work Demands.

Sánchez Sevila JL, Rosas J, Ramada Rodilla JM, Seguí-Crespo M

Ocular immunology and inflammation 2025; (33(3)):423-431 doi:10.1080/09273948.2024.2415539.

Use of immunomodulatory treatment for non-infectious uveitis: an International Ocular Inflammation Society report of real-world practice.

Branford JA, Bodaghi B, Ferreira LB, et al.

The British journal of ophthalmology 2025; (109(4)):482-489 doi:10.1136/bjo-2024-326239.

Automatic measurement of choroidal thickness with swept-source optical coherence tomography in chronic Vogt-Koyanagi-Harada disease: 3 years' follow-up.

Yamamoto-Rodríguez L, Anduaga-Beramendi A, Mediavilla-Vallespín R, et al.

Journal of ophthalmic inflammation and infection 2024; (14(1)):62 doi:10.1186/s12348-024-00445-7.

Comparative effectiveness of disease-modifying antirheumatic drugs for patients with cardiac sarcoidosis.

Brooks L, Kivlin W, Mohananey D, et al.

Rheumatology (Oxford, England) 2025; (64(6)):3303-3308 doi:10.1093/rheumatology/keae692.

CHORIORETINITIS AFTER BACILLUS CALMETTE-GUERIN TREATMENT FOR BLADDER CANCER.

Boopathiraj N, Wagner IV, Powers R, Mashayekhi A

Retinal cases & brief reports 2026; (20(3)):351-354 doi:10.1097/ICB.0000000000001736.

Illness Uncertainty, Burden, and Capacity Among Caregivers of Children With Chronic Uveitis: A Stress and Coping Theory Perspective.

Huang J, Liu R, Huang X, et al.

American journal of ophthalmology 2025; (274()):221-231 doi:10.1016/j.ajo.2025.03.008.

Inherited retinal disease-associated uveitis.

Hung JH, Jain T, Khatri A, et al.

Survey of ophthalmology 2025; (70(5)):951-981 doi:10.1016/j.survophthal.2025.03.011.

Uveitis in Adults: A Review.

Maghsoudlou P, Epps SJ, Guly CM, Dick AD

JAMA 2025; (334(5)):419-434 doi:10.1001/jama.2025.4358.

Etiology and Anatomical Location of Uveitis-Prognostic Factors for Disease Course and Laterality.

Mitkova-Hristova VT, Atanassov MA

Life (Basel, Switzerland) 2025; (15(6)) doi:10.3390/life15060882.

Systematic Review of Clinical Utility of Multimodal Imaging in Noninfectious Posterior Uveitis: MUV Project Report 3.

Accorinti M, Berkenstock MK, Cicinelli MV, et al.

American journal of ophthalmology 2025; (279()):56-77 doi:10.1016/j.ajo.2025.07.002.

Treatment of uveitic macular edema: a review.

Massenzio SS, Zafar S, Deaner JD

Current opinion in ophthalmology 2025; doi:10.1097/ICU.0000000000001161.

Multi-Wavelength Autofluorescence Characteristics and Association With Inflammation in Acute Posterior Multifocal Placoid Pigment Epitheliopathy.

Finger RP, Overbeck LJ, Berger M, et al.

Investigative ophthalmology & visual science 2025; (66(11)):62 doi:10.1167/iovs.66.11.62.

Syphilis and the Eye: Clinical Features, Diagnostic Challenges, and Evolving Therapeutic Paradigms.

Ye Z, Yang M, Zou Y, et al.

Pathogens (Basel, Switzerland) 2025; (14(9)) doi:10.3390/pathogens14090852.

Comparative Outcomes and Side Effects of Immunosuppressants and Tumor Necrosis Factor Inhibitors in Sarcoidosis: A Real-World Data Analysis.

Chao WC, Liao SY

Chest 2026; (169(4)):1006-1017 doi:10.1016/j.chest.2025.09.130.

Clinical and Organizational Determinants of a Frequently Delayed Diagnosis of Ocular Syphilis in a French Referral Center.

Brocquet-Lestrade S, Cazanave C, Delyfer MN, et al.

American journal of ophthalmology 2026; (281()):674-684 doi:10.1016/j.ajo.2025.10.011.

Efficacy and Safety of Switching from Adalimumab Originator to SB5 Biosimilar in Noninfectious Uveitis: Early Clinical Outcomes.

Song JH, Kim C, Chung YR, Kim HR

Journal of clinical medicine 2025; (14(22)) doi:10.3390/jcm14228179.

Recent advances in the diagnosis and treatment of refractory ocular inflammatory diseases: focus on uveitic macular edema, acute retinal necrosis, and vitreoretinal lymphoma.

Takeda A, Yawata N, Sonoda KH

Japanese journal of ophthalmology 2026; (70(1)):18-40 doi:10.1007/s10384-025-01310-3.

Systemic immunosuppressive therapy in idiopathic non-infectious uveitis and scleritis: disease remission, discontinuation, and relapse patterns.

Ferreira AM, Silva MI, Pedrosa AC, et al.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 2026; (264(4)):1089-1100 doi:10.1007/s00417-025-07087-y.

Causes of Visual Loss in Uveitis: A Retrospective Study at a Tertiary Referral Centre.

Al-Roubaie M, Beare N

Cureus 2026; (18(1)):e102183 doi:10.7759/cureus.102183.

The Impact of Vitreoretinal Surgery in Patients with Uveitis: Current Strategies and Emerging Perspectives.

Kalogeropoulos D, Androudi S, Latasiewicz M, et al.

Diagnostics (Basel, Switzerland) 2026; (16(2)) doi:10.3390/diagnostics16020198.

Diagnostic Pars Plana Vitrectomy in Undifferentiated Uveitis: Systematic Review and Meta-Analysis.

Zhang C, AbouKasm G, Lai DA, et al.

Ophthalmology. Retina 2026; (10(6)):581-595 doi:10.1016/j.oret.2026.01.011.

Beyond placoid: diverse clinical presentations and functional outcomes of acute syphilitic posterior placoid chorioretinopathy.

Bianco L, Cicinelli MV, Marchese A, et al.

Eye (London, England) 2026; (40(6)):859-867 doi:10.1038/s41433-026-04272-z.

Laboratory Workup in Pars Plana Diagnostic Vitrectomy: A Real-World Multidisciplinary Retrospective Case Series of Brazilian Patients with Uveitis.

Kato JM, Ferracioli-Oda E, Tanaka T, et al.

Ocular immunology and inflammation 2026; 1-9 doi:10.1080/09273948.2026.2626818.

Treatment adherence in chronic uveitis: What does the MARS-5 tell us?

Caglayan M, Ekinci DY, Dertsiz Kozan B

BMC ophthalmology 2026; (26(1)).

Noninfectious uveitis: Management with biologic agents.

Rathinam SR, Anjana S

Indian journal of ophthalmology 2026; (74(6)):837-844 doi:10.4103/IJO.IJO_3239_25.

Prevalence of Latent and Active Tuberculosis Infection in Inflammatory Bowel Disease Patients Who Received Biological Treatment.

Dashdamirova S, Eskazan T, Erzin YZ, et al.

The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology 2026; (37(5)):564-572 doi:10.5152/tjg.2026.25072.

Clinical performance of the multiplex solid-phase "Direct Strip PCR" for infectious uveitis: a multicenter diagnostic accuracy study.

Nakano S, Sugita S, Takase H, et al.

Japanese journal of ophthalmology 2026; (70(4)):966-982 doi:10.1007/s10384-026-01343-2.

Multimodal Imaging Enhanced by Indocyanine Green Angiography in Syphilitic Uveitis.

Cenachi SPF, Vinciguerra Neto V, de Oliveira Machado Azevedo D, et al.

Ocular immunology and inflammation 2026; (34(4)):826-833 doi:10.1080/09273948.2026.2653100.

Interface Between Ophthalmology and Rheumatology in Uveitis and Retinal Vasculitis in Adult Patients, When Does Who Need Whom?

Kötter I, Stübiger N, Deuter C

Klinische Monatsblatter fur Augenheilkunde 2026; (243(5)):584-589 doi:10.1055/a-2854-8192.

Diagnostic and therapeutic challenges in primary vitreoretinal lymphoma: a practical clinical approach.

Cioboată ML, Tofolean I, Abduraman S, et al.

Romanian journal of ophthalmology 2026; (70(2)):204-215 doi:10.22336/rjo.2026.29.